(Q53906467)

22 May 2018

title

Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. (English)

1 reference

22 May 2018

invasive fungal infections

1 reference

1 reference

Linden P

1

1 reference

22 May 2018

Williams P

series ordinal

2

1 reference

22 May 2018

Chan KM

series ordinal

3

1 reference

22 May 2018

publication date

1 August 2000

1 reference

22 May 2018

published in

Clinical Transplantation

1 reference

22 May 2018

volume

14

1 reference

22 May 2018

issue

4 Pt 1

1 reference

22 May 2018

page(s)

329-339

1 reference

22 May 2018

Fungal infections in solid-organ transplantation

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Intra-abdominal infections in pancreas transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Fungal infections in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Clinical spectrum of fungal infections after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Risk factors for systemic fungal infections in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

The emergence of fungi as major hospital pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Administering amphotericin B--a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Clinical aspects of fungal infection in organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Cyclosporine and itraconazole interaction in heart and lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Drug interactions in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Primary pulmonary involvement of Fusarium solani in a lung transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Candida carriage in the alimentary tract of liver transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Tissue Distribution of Amphotericin B Lipid Complex in Laboratory Animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

Early infections in kidney, heart, and liver transplant recipients on cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Infections in heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Infectious complications in heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Pancreas transplantation at Mayo: III. Multidisciplinary management

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Amphotericin B nephrotoxicity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Ketoconazole and fluconazole inhibition of the metabolism of cyclosporin A by human liver in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

The epidemiology of hematogenous candidiasis caused by different Candida species

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

The contribution of fluconazole to the changing epidemiology of invasive candidal infections

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Effect of food intake on the bioavailability of itraconazole

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Amphotericin B lipid complex in the treatment of invasive fungal infections in liver transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Apophysomyces elegans infection in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2000.140409.X

7 January 2021

10.1034/J.1399-0012.2000.140409.X

Identifiers

DOI

1 reference

22 May 2018

release_htzbsiaen5g6xdbebs5mektwpe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/htzbsiaen5g6xdbebs5mektwpe

24 November 2022

mapped directly with Wikidata item

PubMed ID

10945204

1 reference

22 May 2018